These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7831676)

  • 21. [Standard heparin versus low-molecular-weight heparin].
    Lockner D
    Wien Med Wochenschr; 1999; 149(2-4):37-8. PubMed ID: 10378320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Prevention of postoperative deep vein thrombosis with small doses of heparin].
    Kettunen K; Poikolainen E; Karjalainen P; Oksala I; Alhava E; Rehnberg V; Huttunen H; Mattila M
    Duodecim; 1974; 90(11):834-8. PubMed ID: 4426267
    [No Abstract]   [Full Text] [Related]  

  • 23. Treatment of the patient with deep vein thrombosis.
    Weismantel D
    J Fam Pract; 2001 Mar; 50(3):249-56. PubMed ID: 11252215
    [No Abstract]   [Full Text] [Related]  

  • 24. Anticoagulant therapy for deep vein thrombosis: its proper application.
    Rohrer MJ; Anderson FA
    Semin Vasc Surg; 1996 Mar; 9(1):13-20. PubMed ID: 8665021
    [No Abstract]   [Full Text] [Related]  

  • 25. Comparison of two treatment durations (6 days and 14 days) of a low molecular weight heparin with a 6-day treatment of unfractionated heparin in the initial management of unstable angina or non-Q wave myocardial infarction: FRAX.I.S. (FRAxiparine in Ischaemic Syndrome).
    Eur Heart J; 1999 Nov; 20(21):1553-62. PubMed ID: 10529323
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Drug therapy of deep venous thrombosis].
    Bounameaux H
    Ther Umsch; 1996 Apr; 53(4):272-6. PubMed ID: 8658349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Replacing inpatient care by outpatient care in the treatment of deep venous thrombosis--an economic evaluation. TASMAN Study Group.
    van den Belt AG; Bossuyt PM; Prins MH; Gallus AS; Büller HR
    Thromb Haemost; 1998 Feb; 79(2):259-63. PubMed ID: 9493572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Temporary resistance to heparin and warfarin in treatment of deep vein thrombosis.
    Viswanathan B
    J Kans Med Soc; 1980 Oct; 81(10):468-9. PubMed ID: 7229498
    [No Abstract]   [Full Text] [Related]  

  • 29. Comparative dosage and toxicity of heparin sodium in the treatment of patients with pulmonary embolism versus deep-vein thrombosis.
    Tenero DM; Bell HE; Deitz PA; Bertino JS
    Clin Pharm; 1989 Jan; 8(1):40-3. PubMed ID: 2912663
    [No Abstract]   [Full Text] [Related]  

  • 30. Management of acute deep venous thrombosis.
    Satiani B
    Am Fam Physician; 1982 Apr; 25(4):103-9. PubMed ID: 7064760
    [No Abstract]   [Full Text] [Related]  

  • 31. Subcutaneous adjusted-dose unfractionated heparin vs fixed-dose low-molecular-weight heparin in the initial treatment of venous thromboembolism.
    Prandoni P; Carnovali M; Marchiori A;
    Arch Intern Med; 2004 May; 164(10):1077-83. PubMed ID: 15159264
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Physician-guided treatment compared with a heparin protocol for deep vein thrombosis.
    Elliott CG; Hiltunen SJ; Suchyta M; Hull RD; Raskob GE; Pineo GF; Jensen RL; Yeates S; Kitterman N
    Arch Intern Med; 1994 May; 154(9):999-1004. PubMed ID: 8179457
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The effect of low molecular weight heparin on survival in patients with advanced malignancy.
    Klerk CP; Smorenburg SM; Otten HM; Lensing AW; Prins MH; Piovella F; Prandoni P; Bos MM; Richel DJ; van Tienhoven G; Büller HR
    J Clin Oncol; 2005 Apr; 23(10):2130-5. PubMed ID: 15699479
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The home treatment of deep venous thromboses with low-molecular-weight heparin].
    Grau Segura E; Real Vila E; Pastor Guzmán E; Torró Richart JA; Garay Burdeos M
    Rev Clin Esp; 1997 Jun; 197(6):398-401. PubMed ID: 9304129
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low-dose subcutaneous heparin in prevention of deep-vein thrombosis.
    Drug Ther Bull; 1972 Nov; 10(23):89-91. PubMed ID: 4656672
    [No Abstract]   [Full Text] [Related]  

  • 36. A comparative study of the anticoagulant and anti-thrombotic effects of unfractionated heparin and a low molecular weight heparin (Fraxiparine) in an experimental model of human venous thrombosis.
    Diquélou A; Dupouy D; Cariou R; Sakariassen KS; Boneu B; Cadroy Y
    Thromb Haemost; 1995 Nov; 74(5):1286-92. PubMed ID: 8607111
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Comparison of low-molecular-weight heparin and unfractionated heparin in the treatment of unstable angina].
    Godoy I; Herrera C; Zapata C; Kunstmann S; Abufhele A; Corbalán R
    Rev Med Chil; 1998 Mar; 126(3):259-64. PubMed ID: 9674294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Low molecular weight heparin versus acenocoumarol in the secondary prophylaxis of deep vein thrombosis.
    Lopaciuk S; Bielska-Falda H; Noszczyk W; Bielawiec M; Witkiewicz W; Filipecki S; Michalak J; Ciesielski L; Mackiewicz Z; Czestochowska E; Zawilska K; Cencora A
    Thromb Haemost; 1999 Jan; 81(1):26-31. PubMed ID: 9974369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Should low-molecular-weight heparins replace unfractionated heparin as the agent of choice for adults with deep venous thrombosis?
    Brewer D
    J Fam Pract; 1998 Sep; 47(3):185-92. PubMed ID: 9752370
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Symptomless postoperative thrombosis of the deep calf veins--treatment and prognosis.
    Kneist W; Rödiger H; Nowak W
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(3):401-4. PubMed ID: 2465239
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.